This registry, currently being established will ensure consistency of data collection and provide safety information in non high-risk APS patients currently on DOACs.
Patient receiving a comprehensive information about the study, and not opposed to participate
Age ≥ 18 yo
Classification of definite APS according to revised Sapporo-Sydney criteria
Direct oral anticoagulant treatment prescribed during at least 6 months or with the possibility of follow-up of at least 6 months
Incomplete revised Sapporo-Sydney criteria
No data regarding the recurrent thrombosis
Pregnant woman
Age < 18 yo
Stéphane Zuily
Lead sponsor
Central Hospital, Nancy, France
Sponsor institution
International Society on Thrombosis and Haemostasis
Collaborator